Science Deep Dive Arena Performance
Trauma does not just leave psychological scars, it physically rewires the brain's fear circuitry, shrinks the hippocampus, silences the prefrontal cortex, and recalibrates the stress axis, creating a system that cannot distinguish past threat from present safety.
22 min read
Arena Performance

PTSD and the Brain: What Trauma Does to Memory, Fear, and the Prefrontal Cortex

Trauma does not just leave psychological scars, it physically rewires the brain's fear circuitry, shrinks the hippocampus, silences the prefrontal cortex, and recalibrates the stress axis, creating a system that cannot distinguish past threat from present safety.

Mechanism
Controlled Human Data
Interpretation
Peer-reviewed evidence · Editorial synthesis
— What the Research Actually Found —

Three decades of neuroimaging, genomics, and clinical trials have produced a convergent picture: PTSD is a measurable brain condition with identifiable circuit failures, not a vague psychological label.

Global Trauma Exposure >70 %

More than 70 percent of adults worldwide have experienced at least one significant traumatic event, the raw substrate from which PTSD emerges.[1]

Cross-National Survey
[1]
Economic Burden 232.2 billion USD

The total annual US economic burden of PTSD reaches $232.2 billion, encompassing healthcare, lost productivity, and military-specific costs.[3]

Cost-of-Illness
[3]
Suicide Mortality 2.16 × risk (adjusted)

After full adjustment for prior psychiatric diagnoses and socioeconomic confounders, PTSD independently doubles the risk of death by suicide (HR = 2.16, 95% CI: 1.86–2.50).[36]

National Cohort
[36]
Genetic Architecture 95 risk loci

A genome-wide association study of 1.28 million individuals (~150,760 PTSD cases) identified 95 significant genetic risk loci, 80 of them novel, establishing PTSD as a disorder with measurable biological substrates.[22]

GWAS Meta-Analysis
[22]
48 Peer-reviewed sources
Evidence Signal

Neuroimaging, genetic, and clinical trial evidence converge on the same conclusion: PTSD rewires identifiable brain circuits in measurable, replicable ways.

Study Mix
RCT
14
Meta
8
Cohort
6
Review
20
Editorial Judgment

The mechanistic picture is now clear enough to guide treatment. The remaining gap is not knowledge, it is implementation.

The word trauma comes from the Greek for wound, and for most of medical history that was understood literally, a broken bone, a punctured organ, a visible insult to tissue. The psychological meaning arrived late. Symptoms recognisable as post-traumatic stress appear in Mesopotamian cuneiform tablets more than three thousand years old, in accounts of soldiers who could not stop seeing the faces of the men they had killed.[5] The condition was called shell shock in the First World War, combat fatigue in the Second, and was not granted a formal psychiatric diagnosis until the American Psychiatric Association added post-traumatic stress disorder to the DSM-III in 1980, a gap of roughly three millennia between first observation and official recognition.[5]

That delay was not administrative. It reflected a deeper uncertainty about whether the problem was real in the biological sense, whether trauma did something to the brain, or merely to the mind. The answer, delivered across three decades of neuroimaging, genomics, neuroendocrinology, and controlled clinical trials, is now unambiguous. Trauma physically reorganises the brain. It shrinks structures, silences circuits, recalibrates hormones, and alters gene expression in ways that can be measured on a scan, quantified in a blood draw, and mapped across a genome.[8][9]

The scale of the problem makes the biology urgent. Benjet and colleagues surveyed 68,894 adults across 24 countries (26 surveys) and found that more than 70 percent had experienced at least one significant traumatic event.[1] Of those exposed, roughly 5.6 percent develop PTSD.[2] In the United States, lifetime prevalence sits at approximately 6 percent, with women twice as likely as men to receive the diagnosis.[4] Among high-exposure populations, combat veterans, first responders, survivors of sexual violence, rates climb to between 20 and 57 percent.[6]

Editorial pause
PTSD is not rare, not imagined, and no longer invisible to a scanner. It is a measurable reorganisation of brain architecture triggered by events most humans will face.

DSM-III, 1980, The formal recognition of PTSD as a psychiatric diagnosis ended a century-long debate about whether trauma's effects were physical or purely psychological. The diagnosis created the research category that made everything in this article possible.

What makes PTSD neuroscience different from the neuroscience of ordinary stress is the direction of change. Acute stress activates systems designed to keep you alive: the amygdala fires a threat alarm, cortisol floods the bloodstream, attention narrows. When the threat passes, the prefrontal cortex reasserts control, cortisol levels normalise, and the brain files the event as a completed experience, a process called fear consolidation. PTSD is what happens when that filing process fails.[8][10]

The result is not heightened anxiety. It is a circuit-level reorganisation in which the brain's alarm system runs unchecked, its contextual memory system cannot distinguish past from present, and its hormonal calibration shifts to a baseline that expects danger at all times.[9][11] The economic consequence is staggering: Davis and colleagues calculated the annual US burden at $232.2 billion, or $19,630 per affected individual, with military per-person costs running 38 percent higher.[3]

That framing matters. Performance culture tends to treat trauma responses as psychological weakness, a failure of mental toughness, a problem of mindset. The PTSD neuroscience literature says something entirely different. It says the brain has been physically remodelled by an event, and the remodelling follows predictable biological rules.

Editorial pause
The brain does not simply remember trauma. It reorganises its operating architecture around the expectation that the threat is still present.

This article traces that reorganisation through its component parts: the circuits that malfunction, the structures that change shape, the hormones that recalibrate, and the genes that alter their expression. It examines the five strongest studies in the evidence base, ranks them by methodological weight, and asks what they collectively prove. It maps the consequences, cognitive, cardiovascular, occupational, and mortal, and translates the mechanism into an evidence-based protocol for recovery.

The argument is not that PTSD is complicated. The argument is that PTSD is now understood well enough to describe as a specific set of circuit failures, and that those failures point directly to how treatment works.

"The prefrontal cortex is supposed to tell fear to stand down. In PTSD, it has lost its voice."

— Editorial synthesis, PTSD circuit-failure literature
Editorial pause (Section verdict)
Understanding the mechanism is not academic. It is the prerequisite for knowing what to fix and why the fixes work.
The Mechanism

The Fear Circuit That Breaks in PTSD

Every brain runs a threat-detection system built from the same basic components. A region called the amygdala, a small, almond-shaped cluster buried in the medial temporal lobe, serves as the alarm. It receives sensory information before conscious awareness has time to evaluate it, and when it detects a pattern associated with danger, it triggers a cascade: heart rate rises, muscles tense, attention locks onto the source.[8][9] This is not a malfunction. This is the system working as designed.

The regulation comes from above. The ventromedial prefrontal cortex (vmPFC), the section of prefrontal cortex sitting just behind the bridge of the nose, acts as the brake. Once the amygdala fires, the vmPFC evaluates the context: Is this a real threat? Has this pattern been seen before and found harmless? If the answer is yes, the vmPFC sends inhibitory signals downward, dampening the amygdala's alarm and allowing the body to stand down.[10][14] This process, learning that a previously feared cue is now safe, is called fear extinction, and it depends on the vmPFC and hippocampus working in concert.[15]

In PTSD, this brake fails. Milad and colleagues demonstrated in a controlled fMRI experiment that patients with PTSD show significantly decreased vmPFC activation and greater dorsal anterior cingulate cortex (dACC) activation during extinction recall, meaning the inhibitory circuit that should suppress fear is underactive while the threat-monitoring circuit that should quiet down stays hyperactive.[16] The finding has been replicated in more than 40 subsequent studies.[15][16]

Editorial pause
The vmPFC is supposed to tell the amygdala that the danger has passed. In PTSD, it has lost the authority to override the alarm.

The hippocampus adds a second layer of failure. This structure, critical for episodic memory and contextual processing, tells the amygdala where you are and what that means. A car backfiring in a war zone and a car backfiring in a suburban car park produce the same auditory signal. The hippocampus provides the context that distinguishes them.[10][11]

Logue and colleagues assembled the largest structural neuroimaging dataset in PTSD research: 1,868 individuals across 16 international cohorts in the ENIGMA-PGC consortium. They found significantly smaller hippocampi in PTSD compared with trauma-exposed controls, with a Cohen's d of −0.17 (p = .00054).[11] The effect is modest in magnitude but robust, confirmed simultaneously across 16 independent cohorts, controlling for alcohol use disorder and childhood trauma. Effect sizes vary between military and civilian trauma populations and across PTSD duration, consistent with the understanding that both pre-existing vulnerability and stress-induced atrophy contribute to the finding.[11][12]

Gilbertson's monozygotic twin study resolved the directionality question. By comparing combat-exposed veterans with PTSD to their genetically identical non-combat co-twins, the study found that both brothers shared the same smaller hippocampal volume, establishing that a smaller hippocampus is a pre-existing vulnerability marker, not solely a consequence of trauma.[25]

Editorial pause
The hippocampus tells the amygdala what is safe. When it is structurally compromised, every context begins to look like the original threat.

Below the cortex, two systems amplify the damage. The locus coeruleus (LC), the brain's primary source of norepinephrine, shows hyperactivation in PTSD. Naegeli and colleagues used high-resolution fMRI to demonstrate that PTSD patients exhibit significantly greater LC signal alongside amplified startle, heart rate, and skin conductance responses, with LC activation correlating directly with symptom severity.[20] This is the circuit that drives hypervigilance, exaggerated startle response, and trauma-related nightmares, the arousal symptoms that make PTSD feel like living inside a permanent emergency.[21]

The hypothalamic-pituitary-adrenal axis (HPA axis) completes the picture with a counterintuitive finding. Most people expect a stress disorder to produce elevated cortisol. PTSD does the opposite. Morris and colleagues' meta-analysis of 47 studies (N = 6,008) found that PTSD is associated with significantly reduced daily cortisol output (Cohen's d = −0.36), with the pattern worsening when major depression is comorbid (d = −0.65).[18] The mechanism is enhanced negative feedback sensitivity, a state called hypocortisolism, the HPA axis has been recalibrated to suppress cortisol more aggressively, producing a system that is hypersensitive to acute spikes but runs on depleted baseline reserves.[18][19]

The precise pattern of cortisol output varies by measurement protocol and population, and methodological inconsistency across studies remains a concern, only 2 of 10 qualifying studies in Speer and colleagues' systematic review showed clear altered diurnal patterns.[19] The direction of the finding, however, is consistent: PTSD recalibrates the stress axis, it does not simply amplify it.

Editorial pause
The HPA axis in PTSD has not broken under pressure. It has recalibrated to a new baseline that expects threat as the default condition.

That number, d = −0.17, deserves context. It is a small effect size by conventional standards. In a single individual, the hippocampal volume difference between a PTSD patient and a trauma-exposed control would be difficult to detect on a clinical scan. The significance lies in the consistency: the same direction of effect, confirmed across 16 independent research sites using standardised protocols, in the largest neuroimaging dataset ever assembled for the disorder.[11]

Bromis and colleagues' 89-study meta-analysis extends the structural picture beyond the hippocampus, identifying reduced total brain volume, insula, and anterior cingulate cortex in PTSD, with reduced total brain volume distinguishing PTSD from major depressive disorder, suggesting diagnostic specificity.[12] Xiao and colleagues' multimodal meta-analysis confirms that structural deficits largely explain the functional alterations observed on fMRI.[13]

The genetic layer adds depth to the mechanism. The 2024 Nievergelt GWAS, drawing on approximately 1.28 million individuals including roughly 150,760 PTSD cases, identified 95 genome-wide significant risk loci, regions of single-nucleotide polymorphisms, implicating genes involved in neurotransmitter modulation, synaptic structure, and immune regulation.[22] Twin studies had already established that genetic factors account for 13–34 percent of variance in PTSD symptom clusters, a measure called heritability.[24] The GWAS confirms that this heritability maps onto specific, identifiable genes, moving PTSD firmly into the category of neurodevelopmental conditions with measurable biological substrates.

Editorial pause
The mechanism is not a single broken part. It is a coordinated failure across five systems that produces a brain defending against a threat that no longer exists.

"PTSD is not a failure to forget trauma. It is a failure to remember safety."

— Research synthesis, PTSD neuroscience literature
d = −0.17Cohen's d

hippocampal volume reduction in PTSD versus trauma-exposed controls, the most statistically powered structural neuroimaging finding in the field

Logue et al. (2018) · ENIGMA-PGC Consortium · 16 sites · N = 1,868
The 5 Strongest Studies on PTSD and the Brain

Scored on a 100-point rubric across six criteria, design quality, sample power, measurement rigour, causal clarity, independent replication, and field influence. These five studies collectively establish the neurobiological basis of PTSD.

5

#1
89/100
/100
Logue et al. (2018), Smaller Hippocampal Volume in Posttraumatic Stress Disorder: A Multisite ENIGMA-PGC Study
−0.17 Cohen's d

Mega-Analysis Structural MRI Multi-Site
Design28/30 Sample19/20 Rigour13/15 Causality10/15 Replication10/10 Citations9/10
Supporting evidence · Rank 2–5
Most mechanistically precise controlled experiment
82/100
/100
Milad et al. (2009), Neurobiological Basis of Failure to Recall Extinction Memory in Posttraumatic Stress Disorder
Milad et al.
Decreased vmPFC / increased dACC **Stat unit:** activation
PTSD patients showed significantly decreased vmPFC activation and greater dACC activation during extinction recall, directly mapping the symptom of persistent fear to a specific circuit failure. The finding has been replicated in more than 40 subsequent fMRI studies worldwide.
The prefrontal brake on fear is mechanistically broken in PTSD, extinction memory fails because the vmPFC cannot inhibit the amygdala.
Strongest causal design in PTSD neuroscience
78/100
/100
Gilbertson et al. (2002), Smaller hippocampal volume predicts pathologic vulnerability to psychological trauma
Gilbertson et al.
Equivalent hippocampal volume **Stat unit:** in non-combat co-twins
Non-combat co-twins of PTSD veterans had hippocampal volumes equivalent to their PTSD brothers, significantly smaller than twin pairs without PTSD. Hippocampal volume predicted PTSD symptom severity in the combat-exposed twin.
Smaller hippocampal volume is a pre-existing familial vulnerability marker for PTSD, not solely an acquired consequence of trauma exposure. Both vulnerability and stress-induced atrophy likely contribute.
Largest genetic map of PTSD risk
84/100
/100
Nievergelt et al. (2024), Genome-wide association analyses identify 95 risk loci and provide insights into the neurobiology of PTSD
Nievergelt et al.
95 **Stat unit:** genome-wide significant loci
Identified 95 genome-wide significant loci (80 novel), implicating 43 causal genes across neurotransmitter modulators, synaptic structure genes, and immune regulators. Multi-ancestry design confirms findings generalise beyond European populations. Total sample approximately 1.28 million individuals, including ~150,760 PTSD cases.
PTSD has a measurable, mappable genetic architecture, the disorder is not purely environmental.
Best neuroendocrine evidence
77/100
/100
Morris et al. (2012), Relations among PTSD, Comorbid Major Depression, and HPA Function: A Systematic Review and Meta-Analysis
Morris et al.
−0.36 **Stat unit:** Cohen's d
PTSD is associated with significantly reduced daily cortisol output (d = −0.36); comorbid PTSD and major depression produces a larger deficit (d = −0.65). Enhanced dexamethasone suppression confirms heightened HPA negative feedback, the opposite pattern from acute stress.
PTSD recalibrates the stress axis to a paradoxically hypocortisol state, the neuroendocrine system is not overwhelmed but reset to a lower operating point.
Editorial judgment

The pattern across these four domains is consistent: PTSD's effects are not contained within the psychological sphere. The same circuit failures that produce flashbacks and hypervigilance also impair the cognitive systems required for professional performance, drive inflammatory and autonomic changes that damage the cardiovascular system, and create the neurochemical conditions under which substance dependence and suicidal ideation become biologically facilitated outcomes.[30][32][36]

The economic calculation reinforces the clinical one. At $19,630 per affected individual per year, and with approximately 12 million US adults carrying a current PTSD diagnosis, the aggregate burden exceeds $232 billion annually.[3] That figure does not include the downstream costs of cardiovascular events, substance treatment, or lost productivity in the households of affected individuals.

Editorial pause
PTSD does not stay in the brain. It migrates into the body, the workplace, and the mortality statistics with measurable, quantifiable force.
What Breaks When the Circuit Breaks

The Cost of a Brain That Cannot Stand Down

PTSD's circuit failures do not stay inside the skull. They cascade outward into cognition, cardiovascular health, occupational function, and survival itself.

Cognitive
Verbal Learning and Processing Speed
Scott and colleagues' 60-study meta-analysis (N = 4,108) found the largest neurocognitive deficits in verbal learning (d = −0.62) and information processing speed (d = −0.59).[30] Petzold and Bunzeck's 47-study meta-analysis confirmed medium-magnitude episodic memory impairment (d = −0.50).[31] These deficits are not explained by trauma exposure alone, they are specific to the PTSD diagnosis.
What it feels like · difficulty concentrating, words slipping away mid-sentence, reading the same paragraph three times
Cardiovascular
Heart Disease and Stroke
Edmondson's meta-analysis of 402,274 individuals found PTSD confers a 55 percent increased risk of coronary heart disease (HR = 1.55), with 27 percent remaining after controlling for depression.[32] Padhi's 20-study analysis found stroke risk more than doubles (HR = 2.07).[33] PTSD is an independent cardiovascular risk factor, not mediated entirely through depression or lifestyle.
What it feels like · unexplained chest tightness, elevated resting heart rate, a body perpetually braced for impact
Substance Use and Occupation
Comorbidity and Work Capacity
Approximately 46.4 percent of PTSD patients meet criteria for a co-occurring substance use disorder, a rate 2–4 times higher than the non-PTSD population.[34] Brenner and colleagues found that 74.6 percent of PTSD patients and 87.5 percent of those with complex PTSD were unable to work.[35] The occupational impact alone makes PTSD a workforce-level economic event.
What it feels like · self-medicating to sleep, calling in sick, the slow erosion of professional identity
Mortality
Suicide Risk
Fox and colleagues' nationwide Swedish cohort (N = 3.1 million) found that PTSD independently doubles the risk of death by suicide after full adjustment for prior psychiatric diagnoses: HR = 2.16 (95% CI: 1.86–2.50).[36] Crude mortality rates, 53.9 versus 12.9 per 100,000, illustrate the raw incidence gap, though the adjusted figure is the defensible risk estimate. This is not comorbid depression driving the finding. It is PTSD itself.
95%
What it feels like · exhaustion that sleep cannot fix, a narrowing of reasons to continue, the conviction that nothing will change
1 / 4

The protocol is deliberately not a wellness plan. It is a circuit-restoration strategy that follows directly from the mechanism described in this article. Every step targets a specific biological system identified in the evidence: Step 01 targets vmPFC-amygdala inhibitory failure. Step 02 offers an equivalent route through a different therapeutic modality. Step 03 modulates the noradrenergic and serotonergic systems pharmacologically when the circuit is too dysregulated for psychotherapy alone. Step 04 creates the neuroplastic conditions under which structural recovery becomes possible.

The evidence is strongest for Steps 01 and 02, both carry high-strength guideline endorsements from multiple international bodies.[40][43] Pharmacotherapy (Step 03) carries weaker evidence as a standalone treatment. Neuroplasticity support (Step 04) has the least direct RCT evidence but the strongest mechanistic rationale.

Editorial pause
The protocol does not ask the brain to forget the trauma. It asks the prefrontal cortex to re-learn that the emergency is over.
Translation Layer · What the Evidence Supports

An Evidence-Based PTSD Recovery Protocol

Every evidence-based PTSD treatment works by the same underlying mechanism: repeated exposure to the threat cue in a context where the prefrontal cortex can re-learn safety. The steps differ in method. The biology is identical.

01
Weeks 1–15
Trauma-Focused Psychotherapy
Rule
Engage in Prolonged Exposure or Cognitive Processing Therapy with a trained clinician, 8–15 weekly sessions.
SMD = 0.99
Why
PE retrains the vmPFC's inhibitory control through direct confrontation with trauma memories, a process called imaginal exposure; CPT targets the maladaptive appraisals maintaining the threat state. Schnurr's 916-patient RCT, the largest PTSD psychotherapy trial, found PE produced large symptom reductions (SMD = 0.99); Asmundson's meta-analysis found the average CPT patient fared better than 89 percent of controls.[39][41]
Common mistake
Avoiding trauma-focused therapy out of fear of symptom worsening. Avoidance maintains the fear circuit. Controlled exposure under therapeutic support is the corrective mechanism.
02
Alternative
EMDR as First-Line Equivalent
Rule
Consider EMDR (6–12 sessions) as a guideline-endorsed alternative with equivalent effect sizes.
Why
Chen's 26-RCT meta-analysis found significant PTSD symptom reduction (Hedges' g = −0.662) and depression reduction (g = −0.643).[42] International guidelines, APA, NICE, ISTSS, endorse EMDR as a first-line treatment equivalent to trauma-focused CBT.[43] The specific contribution of the eye movement component remains scientifically contested; efficacy does not depend on resolving that question.
Common mistake
Dismissing EMDR as "alternative medicine." The effect sizes are equivalent to PE and CPT in head-to-head comparisons.
03
Adjunct
Pharmacotherapy When Needed
Rule
Use sertraline or paroxetine as adjuncts when psychotherapy alone is insufficient, not as a substitute for trauma-focused therapy.
N = 67
Why
Jia's 52-RCT meta-analysis found an overall pharmacological response rate of 39 percent, substantially lower than the psychotherapy response rates.[46] Prazosin, which targets the noradrenergic arousal circuit, showed promise in a smaller trial (N = 67) but a larger NEJM trial (N = 304) found null results on all primary outcomes, clinician discretion is warranted rather than routine prescription.[44][45]
Common mistake
Using medication as a replacement for trauma-focused therapy. Pharmacotherapy manages symptoms; only exposure-based therapy addresses the circuit deficit that maintains the disorder.
04
Ongoing
Neuroplasticity Support
Rule
Sustain the biological conditions that enable hippocampal neurogenesis and prefrontal recovery, aerobic exercise (≥150 min/week), consistent sleep architecture (±30 min), alcohol avoidance.
Why
Bremner's data showed SSRI treatment (paroxetine) produced a 5 percent hippocampal volume increase at 9 months alongside 30 percent verbal memory improvement, demonstrating that the brain retains structural plasticity post-trauma.[47] Preliminary fMRI evidence suggests PE restores amygdala-hippocampus-vmPFC connectivity.[48]
Common mistake
Treating PTSD as purely psychological. The biological substrate, hippocampal volume, cortisol calibration, synaptic connectivity, is modifiable, and modifying it supports the psychological work.
1 / 4

These four steps share a common logic: restore the prefrontal cortex's capacity to inhibit fear, provide the hippocampus with conditions for structural recovery, and recalibrate the stress axis through controlled exposure rather than avoidance.

The Verdict
01
Claim
Circuit, Not Character
PTSD is a measurable failure of the brain's threat-processing infrastructure, a hyperactive amygdala, a silenced prefrontal cortex, a structurally compromised hippocampus, and a recalibrated stress axis. The evidence base includes the largest neuroimaging consortium study, the cleanest controlled fMRI experiment, and the most comprehensive GWAS ever conducted for the disorder.
02
Consequence
Cascade Beyond the Brain
Left unaddressed, the circuit failure cascades into cognitive impairment, cardiovascular disease, substance dependence, occupational disability, and a more than doubled risk of death by suicide. The annual US economic burden exceeds $232 billion, a figure that understates the human cost.
03
Lever
Re-learning Safety
Every evidence-based treatment works by the same mechanism: restoring the prefrontal cortex's authority to inhibit fear and providing the hippocampus with conditions for structural recovery. The circuit that learned danger can learn safety, but only through controlled exposure, not avoidance.
High
High Confidence
Convergent evidence from mega-analysis neuroimaging, controlled fMRI experiments, multi-ancestry GWAS, neuroendocrine meta-analyses, and large-scale RCTs, replicated across independent research groups worldwide

References

0 sources cited — peer-reviewed sources

  1. 1Benjet, C., Bromet, E., Karam, E. G., Kessler, R. C., McLaughlin, K. A., Ruscio, A. M., et al. (2016). The epidemiology of traumatic event exposure worldwide: results from the World Mental Health Survey Consortium. Psychological Medicine, 46(2), 327–343. DOI: 10.1017/S0033291715001981
  2. 2Koenen, K. C., Ratanatharathorn, A., Ng, L., McLaughlin, K. A., Bromet, E. J., Stein, D. J., et al. (2017). Posttraumatic stress disorder in the World Mental Health Surveys. Psychological Medicine, 47(13), 2260–2274. DOI: 10.1017/S0033291717000708
  3. 3Davis, L. L., Schein, J., Cloutier, M., Gagnon-Sanschagrin, P., Maitland, J., Urganus, A., Guerin, A., Lefebvre, P., & Houle, C. R. (2022). The Economic Burden of Posttraumatic Stress Disorder in the United States From a Societal Perspective. Journal of Clinical Psychiatry, 83(3), 21m14116. DOI: 10.4088/JCP.21m14116
  4. 4Kessler, R. C., Sonnega, A., Bromet, E., Hughes, M., & Nelson, C. B. (1995). Posttraumatic stress disorder in the National Comorbidity Survey. Archives of General Psychiatry, 52(12), 1048–1060. DOI: 10.1001/archpsyc.1995.03950240066012
  5. 5Crocq, M. A., & Crocq, L. (2000). From shell shock and war neurosis to posttraumatic stress disorder: a history of psychotraumatology. Dialogues in Clinical Neuroscience, 2(1), 47–55. DOI: 10.31887/DCNS.2000.2.1/macrocq
  6. 6Obuobi-Donkor, G., Oluwasina, F., Nkire, N., & Agyapong, V. I. O. (2022). A Scoping Review on the Prevalence and Determinants of Post-Traumatic Stress Disorder among Military Personnel and Firefighters. International Journal of Environmental Research and Public Health, 19(3), 1565. DOI: 10.3390/ijerph19031565
  7. 7Kazlauskas, E. (2017). Challenges for providing health care in traumatized populations: barriers for PTSD treatments and the need for new developments. Global Health Action, 10(1), 1322399. DOI: 10.1080/16549716.2017.1322399
  8. 8Pitman, R. K., Rasmusson, A. M., Koenen, K. C., Shin, L. M., Orr, S. P., Gilbertson, M. W., Milad, M. R., & Liberzon, I. (2012). Biological studies of post-traumatic stress disorder. Nature Reviews Neuroscience, 13(11), 769–787. DOI: 10.1038/nrn3339
  9. 9Shin, L. M., & Liberzon, I. (2010). The neurocircuitry of fear, stress, and anxiety disorders. Neuropsychopharmacology, 35(1), 169–191. DOI: 10.1038/npp.2009.83
  10. 10Liberzon, I., & Abelson, J. L. (2016). Context Processing and the Neurobiology of Post-Traumatic Stress Disorder. Neuron, 92(1), 14–30. DOI: 10.1016/j.neuron.2016.09.039
  11. 11Logue, M. W., van Rooij, S. J. H., Dennis, E. L., Davis, S. L., Hayes, J. P., Stevens, J. S., et al. (2018). Smaller Hippocampal Volume in Posttraumatic Stress Disorder: A Multisite ENIGMA-PGC Study. Biological Psychiatry, 83(3), 244–253. DOI: 10.1016/j.biopsych.2017.09.006
  12. 12Bromis, K., Calem, M., Reinders, A. A. T. S., Williams, S. C. R., & Kempton, M. J. (2018). Meta-Analysis of 89 Structural MRI Studies in Posttraumatic Stress Disorder and Comparison With Major Depressive Disorder. American Journal of Psychiatry, 175(10), 989–998. DOI: 10.1176/appi.ajp.2018.17111199
  13. 13Xiao, S., Yang, Z., Su, T., Gong, J., Huang, L., & Wang, Y. (2022). Functional and structural brain abnormalities in posttraumatic stress disorder: A multimodal meta-analysis of neuroimaging studies. Journal of Psychiatric Research, 154, 10–18. DOI: 10.1016/j.jpsychires.2022.08.010
  14. 14Milad, M. R., Wright, C. I., Orr, S. P., Pitman, R. K., Quirk, G. J., & Rauch, S. L. (2007). Recall of fear extinction in humans activates the ventromedial prefrontal cortex and hippocampus in concert. Biological Psychiatry, 61(9), 1016–1023. DOI: 10.1016/j.biopsych.2006.10.011
  15. 15Milad, M. R., & Quirk, G. J. (2012). Fear extinction as a model for translational neuroscience: Ten years of progress. Annual Review of Psychology, 63, 129–151. DOI: 10.1146/annurev.psych.121208.131631
  16. 16Milad, M. R., Pitman, R. K., Ellis, C. B., Gold, A. L., Shin, L. M., Lasko, N. B., Zeidan, M. A., Handwerger, K., Orr, S. P., & Rauch, S. L. (2009). Neurobiological Basis of Failure to Recall Extinction Memory in Posttraumatic Stress Disorder. Biological Psychiatry, 66(12), 1075–1082. DOI: 10.1016/j.biopsych.2009.06.026
  17. 17Wen, Z., Seo, J., Pace-Schott, E. F., & Milad, M. R. (2022). Abnormal dynamic functional connectivity during fear extinction learning in PTSD and anxiety disorders. Molecular Psychiatry, 27(9), 3768–3778. DOI: 10.1038/s41380-022-01462-5
  18. 18Morris, M. C., Compas, B. E., & Garber, J. (2012). Relations among Posttraumatic Stress Disorder, Comorbid Major Depression, and HPA Function: A Systematic Review and Meta-Analysis. Clinical Psychology Review, 32(4), 301–315. DOI: 10.1016/j.cpr.2012.02.002
  19. 19Speer, K. E., Semple, S., Naumovski, N., D'Cunha, N. M., & McKune, A. J. (2019). HPA axis function and diurnal cortisol in post-traumatic stress disorder: A systematic review. Neurobiology of Stress, 11, 100180. DOI: 10.1016/j.ynstr.2019.100180
  20. 20Naegeli, C., Zeffiro, T., Piccirelli, M., Jaillard, A., Weilenmann, A., Hassanpour, K., Schick, M., Rufer, M., Orr, S. P., & Mueller-Pfeiffer, C. (2018). Locus Coeruleus Activity Mediates Hyperresponsiveness in Posttraumatic Stress Disorder. Biological Psychiatry, 83(3), 254–262. DOI: 10.1016/j.biopsych.2017.08.021
  21. 21Hendrickson, R. C., & Raskind, M. A. (2016). Noradrenergic dysregulation in the pathophysiology of PTSD. Experimental Neurology, 284(Pt B), 181–195. DOI: 10.1016/j.expneurol.2016.05.014
  22. 22Nievergelt, C. M., Maihofer, A. X., et al. (2024). Genome-wide association analyses identify 95 risk loci and provide insights into the neurobiology of post-traumatic stress disorder. Nature Genetics. DOI: 10.1038/s41588-024-01707-9
  23. 23Nievergelt, C. M., Maihofer, A. X., Klengel, T., et al. (2019). International meta-analysis of PTSD genome-wide association studies identifies sex- and ancestry-specific genetic risk loci. Nature Communications, 10, 4558. DOI: 10.1038/s41467-019-12576-w
  24. 24True, W. R., Rice, J., Eisen, S. A., Heath, A. C., Goldberg, J., Lyons, M. J., & Nowak, J. (1993). A twin study of genetic and environmental contributions to liability for posttraumatic stress disorder. Archives of General Psychiatry, 50(4), 257–264. DOI: 10.1001/archpsyc.1993.01820160019002
  25. 25Gilbertson, M. W., Shenton, M. E., Ciszewski, A., Kasai, K., Lasko, N. B., Orr, S. P., & Pitman, R. K. (2002). Smaller hippocampal volume predicts pathologic vulnerability to psychological trauma. Nature Neuroscience, 5(11), 1242–1247. DOI: 10.1038/nn958
  26. 26Klengel, T., Mehta, D., Anacker, C., Rex-Haffner, M., Pruessner, J. C., Pariante, C. M., Pace, T. W., Mercer, K. B., Mayberg, H. S., Bradley, B., Binder, E. B., & Ressler, K. J. (2013). Allele-specific FKBP5 DNA demethylation mediates gene–childhood trauma interactions. Nature Neuroscience, 16(1), 33–41. DOI: 10.1038/nn.3275
  27. 27Yehuda, R., Daskalakis, N. P., Bierer, L. M., Bader, H. N., Klengel, T., Holsboer, F., & Binder, E. B. (2016). Holocaust Exposure Induced Intergenerational Effects on FKBP5 Methylation. Biological Psychiatry, 80(5), 372–380. DOI: 10.1016/j.biopsych.2015.08.005
  28. 28Harnett, N. G., Finegold, K. E., Lebois, L. A. M., van Rooij, S. J. H., Ely, T. D., Murty, V. P., et al. (2021). Prognostic neuroimaging biomarkers of trauma-related psychopathology: resting-state fMRI shortly after trauma predicts future PTSD and depression symptoms in the AURORA study. Neuropsychopharmacology, 46(7), 1263–1271. DOI: 10.1038/s41386-020-00946-8
  29. 29Atwoli, L., Stein, D. J., Koenen, K. C., & McLaughlin, K. A. (2015). Epidemiology of posttraumatic stress disorder: prevalence, correlates and consequences. Current Opinion in Psychiatry, 28(4), 307–311. DOI: 10.1097/YCO.0000000000000167
  30. 30Scott, J. C., Matt, G. E., Wrocklage, K. M., Crnich, C., Jordan, J., Southwick, S. M., Krystal, J. H., & Schweinsburg, B. C. (2014). A quantitative meta-analysis of neurocognitive functioning in posttraumatic stress disorder. Psychological Bulletin, 141(1), 105–140. DOI: 10.1037/a0038039
  31. 31Petzold, M., & Bunzeck, N. (2022). Impaired episodic memory in PTSD patients, A meta-analysis of 47 studies. Frontiers in Psychiatry, 13, 909442. DOI: 10.3389/fpsyt.2022.909442
  32. 32Edmondson, D., Kronish, I. M., Shaffer, J. A., Falzon, L., & Burg, M. M. (2013). Posttraumatic stress disorder and risk for coronary heart disease: A meta-analytic review. American Heart Journal, 166(5), 806–814. DOI: 10.1016/j.ahj.2013.07.031
  33. 33Padhi, B. K., Khatib, M. N., Abu Serhan, H., Gaidhane, A. M., Rustagi, S., Zahiruddin, Q. S., Sharma, R. K., & Satapathy, P. (2024). Cardiovascular impact of post-traumatic stress disorder: A systematic review and meta-analysis. Current Problems in Cardiology, 49(8), 102632. DOI: 10.1016/j.cpcardiol.2024.102632
  34. 34McCauley, J. L., Killeen, T., Gros, D. F., Brady, K. T., & Back, S. E. (2012). Posttraumatic stress disorder and co-occurring substance use disorders: Advances in assessment and treatment. Clinical Psychology: Science and Practice, 19(3), 283–304. DOI: 10.1111/cpsp.12006
  35. 35Brenner, L., Köllner, V., & Bachem, R. (2019). Symptom burden and work-related impairment among patients with PTSD and complex PTSD. European Journal of Psychotraumatology, 10(1), 1694766. DOI: 10.1080/20008198.2019.1694766
  36. 36Fox, V., Dalman, C., Dal, H., Hollander, A.-C., Kirkbride, J. B., & Pitman, A. (2021). Suicide risk in people with post-traumatic stress disorder: A cohort study of 3.1 million people in Sweden. Journal of Affective Disorders, 279, 609–616. DOI: 10.1016/j.jad.2020.10.009
  37. 37Perroud, N., Paoloni-Giacobino, A., Prada, P., et al. (2011). Increased methylation of glucocorticoid receptor gene (NR3C1) in adults with a history of childhood maltreatment. International Journal of Neuropsychopharmacology, 14(3), 307–317. DOI: 10.1017/S1461145710000999
  38. 38Tyrka, A. R., Price, L. H., Marsit, C., Walters, O. C., & Carpenter, L. L. (2012). Methylation of the leukocyte glucocorticoid receptor gene promoter in adults: associations with early adversity and depressive, anxiety and substance-use disorders. Translational Psychiatry, 2(4), e4. DOI: 10.1038/tp.2012.4
  39. 39Schnurr, P. P., Chard, K. M., Ruzek, J. I., Chow, B. K., Resick, P. A., Foa, E. B., et al. (2022). Comparison of Prolonged Exposure vs Cognitive Processing Therapy for Treatment of PTSD Among US Veterans: A Randomized Clinical Trial. JAMA Network Open, 5(1), e2136921. DOI: 10.1001/jamanetworkopen.2021.36921
  40. 40McLean, C. P., & Foa, E. B. (2024). State of the science: Prolonged exposure therapy for the treatment of posttraumatic stress disorder. Journal of Traumatic Stress, 37(4), 535–550. DOI: 10.1002/jts.23046
  41. 41Asmundson, G. J. G., Thorisdottir, A. S., Roden-Foreman, J. W., et al. (2019). A meta-analytic review of cognitive processing therapy for adults with posttraumatic stress disorder. Cognitive Behaviour Therapy, 48(1), 1–14. DOI: 10.1080/16506073.2018.1522371
  42. 42Chen, Y.-R., Hung, K.-W., Tsai, J.-C., et al. (2014). Efficacy of eye-movement desensitization and reprocessing for patients with posttraumatic-stress disorder: A meta-analysis of randomized controlled trials. PLoS One, 9(8), e103676. DOI: 10.1371/journal.pone.0103676
  43. 43de Jongh, A., de Roos, C., & El-Leithy, S. (2024). State of the science: Eye movement desensitization and reprocessing (EMDR) therapy. Journal of Traumatic Stress, 37(2), 205–216. DOI: 10.1002/jts.23012
  44. 44Raskind, M. A., Peterson, K., Williams, T., et al. (2013). A trial of prazosin for combat trauma PTSD with nightmares in active-duty soldiers returned from Iraq and Afghanistan. American Journal of Psychiatry, 170(9), 1003–1010. DOI: 10.1176/appi.ajp.2013.12081133
  45. 45Raskind, M. A., Peskind, E. R., Chow, B., et al. (2018). Trial of prazosin for post-traumatic stress disorder in military veterans. New England Journal of Medicine, 378(6), 507–517. DOI: 10.1056/NEJMoa1507598
  46. 46Jia, Y., Ye, Z., Yang, F., et al. (2025). Pharmacotherapy for post-traumatic stress disorder: systematic review and meta-analysis. Therapeutic Advances in Psychopharmacology, 15, 20451253251342628. DOI: 10.1177/20451253251342628
  47. 47Bremner, J. D., Elzinga, B., Schmahl, C., & Vermetten, E. (2008). Structural and functional plasticity of the human brain in posttraumatic stress disorder. Progress in Brain Research, 167, 171–186. DOI: 10.1016/S0079-6123(07)67012-5
  48. 48Zhu, X., Suarez-Jimenez, B., Lazarov, A., et al. (2018). Exposure-based therapy changes amygdala and hippocampus resting-state functional connectivity in patients with PTSD. Depression and Anxiety, 35(10), 974–984. DOI: 10.1002/da.22816 --- ## METADATA ### Word Count Targets | Block | Target | Actual | |-------|--------|--------| | Masthead | 50–100 | 82 | | Key Findings | 150–250 | 210 | | Opening | 600–900 | 870 | | Mechanism | 1,500–2,500 | 1,680 | | Evidence | 1,200–1,800 | 1,520 | | Stakes | 500–800 | 680 | | Protocol | 500–800 | 720 | | Verdict | 400–700 | 590 | | *TOTAL | 4,900–7,850 | ~5,800 | ### Stat Collision Check | Stat | Appears in blocks | Varied framing? | |------|-------------------|-----------------| | d = −0.17 (hippocampus) | Mechanism, Evidence, Key Findings (indirect) | Yes, Mechanism uses full context, Evidence uses study ranking, KF references via description | | $232.2 billion | Key Findings, Opening, Stakes | Yes, KF: headline stat; Opening: economic context; Stakes: per-person cost framing | | HR = 2.16 (suicide) | Key Findings, Stakes | Yes, KF: headline stat with CI; Stakes: adjusted vs crude rates contextualized | | 95 loci | Key Findings, Evidence | Yes, KF: headline stat; Evidence: detailed GWAS context with case/control breakdown | ### dfn Terms per Block | Block | Count | Terms | |-------|-------|-------| | Opening | 6 | shell shock, combat fatigue, post-traumatic stress disorder, amygdala, prefrontal cortex, fear consolidation | | Mechanism | 15 | amygdala, ventromedial prefrontal cortex, fear extinction, hippocampus, dorsal anterior cingulate cortex, episodic memory, contextual processing, locus coeruleus, norepinephrine, hypervigilance, startle response, hypothalamic-pituitary-adrenal axis, negative feedback sensitivity, hypocortisolism, heritability | | Evidence | 8 | FKBP5, glucocorticoid receptor, intergenerational epigenetic transmission, default mode network, central executive network, salience network, single-nucleotide polymorphisms, neurotransmitter modulation | | Stakes | 2 | substance use disorder, complex PTSD | | Protocol | 3 | imaginal exposure, maladaptive appraisals, hippocampal neurogenesis, SSRI | | Verdict | 1 | extinction learning | | TOTAL | 35 | | ### Internal Links | Target | Clean URL | Used in block | |--------|-----------|---------------| | Burnout SDD | /arena/burnout/science/ |, (available for Coder cross-link) | | Acute Stress SDD | /arena/crisis/acute-stress-neuroscience/ |, (available for Coder cross-link) | ### Editorial Pause Inventory | Block | Pause count | Labels used | |-------|-------------|-------------| | Opening | 3 | Editorial pause, Editorial pause, Section verdict | | Mechanism | 4 | Editorial pause ×4 | | Evidence | 3 | Editorial pause ×2, Section verdict | | Stakes | 1 | Editorial pause | | Protocol | 1 | Editorial pause | | Verdict | 1 | Final line | | TOTAL | 13* | | ### Pull Quote Inventory | Block | Quote text | Attribution | Word count | |-------|-----------|-------------|------------| | Opening | "The prefrontal cortex is supposed to tell fear to stand down. In PTSD, it has lost its voice." | Editorial synthesis, PTSD circuit-failure literature | 19 | | Mechanism | "PTSD is not a failure to forget trauma. It is a failure to remember safety." | Research synthesis, PTSD neuroscience literature | 16 |
No references match your search.

DOI links resolve to the original publisher via doi.org. Open-access versions can often be found via Google Scholar.

High-Performance Insights

Leave a Reply

Your email address will not be published. Required fields are marked *